ArticlePharmacoEconomics2020

Cost-Effectiveness Analysis of Vedolizumab Compared with Other Biologics in Anti-TNF-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan.

Luis Hernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.